Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04146558Phase 3Completed
Phase 3, randomised, open-label trial in plaque psoriasis (2 arms), sponsored by University of Duisburg-Essen. Primary endpoint: Psoriasis-specific Quality of Life at 6 months. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04146558.